1.Status and correlation of occupational attractiveness and career expectancy in nursing undergraduate and postgraduates at internship
Yang WANG ; Jiahong LIU ; Qi YAN
Modern Clinical Nursing 2018;17(3):1-5
Objective To understand the status quo of occupational attractiveness and career expectancy in nursing undergraduate and postgraduates at internship and explore the correlation between them. Method A total of 60 nursing undergraduate and 25 nursing postgraduates were enrolled in the investigation by using general information questionnaire,occupational attractiveness scale and occupational expectancy scale. Results The score on the occupational attractiveness (9.91 ±2.84)and the score on career expectations (81.83±12.72).The scores on occupational attractiveness and career expectancy among the undergraduate were significantly higher than those among the postgraduates (t=1.971,P<0.05).The occupational attractiveness of clinical nursing students at internship was positively correlated with occupational expectancy, stability factors and self-development factors (P<0.05). Conclusions The occupational attractiveness and career expectations of nursing undergraduates and postgraduates during internship are both at a low level. The occupational attractiveness and career expectations among them are positively correlated.It is indicated that in school education the guidance of expanding professional values should be enhanced;and in clinical practice the clinical teaching and theoretical teaching should be aimed to improve the occupational attractiveness and career expectations so as to cultivate high-quality nursing talents and stabilize the nursing team.
2.Research progress on kinesiophobia of breast cancer survivors
Limei WANG ; Lu LI ; Lihui YE ; Jiahong QI ; Yuxia LI
Chinese Journal of Modern Nursing 2024;30(14):1955-1960
This article summarizes the overview, occurrence, adverse effects, assessment tools, influencing factors and interventions of kinesiophobia in breast cancer survivors, with a view to providing basis for preventing and reducing the occurrence of kinesiophobia in breast cancer survivors, improving the rehabilitation effect and the quality of life.
3.Therapeutic inhibition of SGK1 suppresses colorectal cancer.
Xuchun LIANG ; Chunling LAN ; Guanming JIAO ; Wencheng FU ; Xuesha LONG ; Yu AN ; Kejin WANG ; Jinzhe ZHOU ; Ting CHEN ; Yongqin LI ; Jiahong XU ; Qi HUANG ; Bin XU ; Junjie XIAO
Experimental & Molecular Medicine 2017;49(11):e399-
Colorectal cancer (CRC) is one of the leading causes of death worldwide. Thus, the development of new therapeutic targets for CRC treatment is urgently needed. SGK1 is involved in various cellular activities, and its dysregulation can result in multiple cancers. However, little is known about its roles and associated molecular mechanisms in CRC. In present study, we found that SGK1 was highly expressed in tumor tissues compared with peri-tumor samples from CRC patients. In vitro experiments revealed that SGK1 overexpression promoted colonic tumor cell proliferation and migration and inhibited cell apoptosis induced by 5-fluorouracil (5-FU), while SGK1 shRNA and inhibitors showed the inverse effects. Using CRC xenograft mice models, we demonstrated that knockdown or therapeutic inhibition of SGK1 repressed tumor cell proliferation and tumor growth. Moreover, SGK1 inhibitors increased p27 expression and promoted p27 nuclear accumulation in colorectal cancer cells, and p27 siRNAs could attenuate the repression of CRC cell proliferation induced by SGK1 inhibitors. Collectively, SGK1 promotes colorectal cancer development via regulation of CRC cell proliferation, migration and survival. Inhibition of SGK1 represents a novel strategy for the treatment of CRC.
Animals
;
Apoptosis
;
Cause of Death
;
Cell Proliferation
;
Colon
;
Colorectal Neoplasms*
;
Fluorouracil
;
Heterografts
;
Humans
;
In Vitro Techniques
;
Mice
;
Repression, Psychology
;
RNA, Small Interfering
4.Detection rate of hypertension in elderly patients of Deang nationality and multilevel model of its influencing factors
Yong MAO ; Jia ZHOU ; Tianshu CHU ; Songmei WANG ; Chenghuan SUN ; Jiahong LUO ; Chunmi LAI ; Bingxian QI ; Qian ZHANG
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2018;20(1):16-19
Objective To study the influencing factors of primary hypertension by investigating its prevalence in elderly patients of Deang nationality.Methods Nine hundred and thirty-nine elderly patients of Deang nationality were divided into hypertension group (n =353),prehypertension group (n=377) and control group (n=209).Their physical examination data were recorded and their blood pressure was measured.Results The detection rate of hypertension was significantly lower in elderly patients of Deang nationality than in those of the other nationalities in our country with their age ≥60 years (37.6% vs 49.0%,P<0.05).The detection rate of hypertension,isolated systolic hypertension and prehypertension increased with the increasing age (P<0.05).Multivariate logistic regression analysis showed a cross interaction between economic level and alcohol drinking (P<0.05) and a positive correlation of BMI,age,gender,divorce or widow,smonking,high salt diet with hypertension (P<0.05).Conclusion The detection rate of hypertension is lower in elderly patients of Deang nationality than in those of the other nationalities in our country.Economic level,alcohol drinking,BMI,age,gender,divorce or widow,smoking,high salt and fat diet are the major risk factors for hypertension.However,regular eating of vegetables can reduce the risk of hypertension.
5.Summary of the Twenty?ninth International Symposium on Amyotrophic Lateral Sclerosis?Motor Neuron Disease
Xusheng HUANG ; Liying CUI ; Dongsheng FAN ; Xiaoguang LI ; Mingsheng LIU ; Huifang SHANG ; Xiaoli YAO ; Jiahong LU ; Min ZHANG ; Yan CHEN ; Qi NIU ; Xueping CHEN
Chinese Journal of Neurology 2019;52(10):866-871
The 29th International Symposium on Amyotrophic Lateral Sclerosis (ALS)?Motor Neuron Disease was held in Glasgow from December 7 to 9, 2018. The symposium was divided into 23 topics, with 109 special reports and paper′s exchange and 515 posters exchange. This article briefly introduces some topics of the symposium, involving basic researches, clinical researches and clinical trials. Among these, basic researches include genetics and genomics, axonal degeneration, disease models, and preclinical therapeutic strategies; Clinical researches include epidemiology, clinical progression, cognitive and psychological change, neuropathology, neurophysiology, neuroimaging and biomarkers.
6.Safety and efficacy of botulinum toxin type A made in China for treatment of post-stroke upper limb spasticity: a randomized double-blind controlled trial
Yingmai YANG ; Qi LIANG ; Xinhua WAN ; Lin WANG ; Suling CHEN ; Qiang WU ; Xueping ZHANG ; Shengyuan YU ; Huifang SHANG ; Xingyue HU ; Jiahong LU ; Enxiang TAO ; Zhiyu NIE ; Xudong PAN ; Ronghua TANG ; Baorong ZHANG ; Jun CHEN ; Hongyu TAN ; Hongjuan DONG ; Jian'an LI ; Weifeng LUO ; Chen YAO
Chinese Journal of Neurology 2018;51(5):355-363
Objective To evaluate the safety and efficacy of botulinum toxin type A for injection in the treatment of post-stroke upper limb spasticity (dosage was 200 U,or 240 U if combined with thumb spasticity).Methods The study was a multi-center,stratified block randomized,double-blind,placebocontrolled trial.All the qualificd subjects were from 15 clinical centers from September 2014 to February 2016.They were randomized (2∶1) to injections of botulinum toxin type A made in China (200-240 U;n =118) or placebo (n =60) in pivotal phase after informed consent signed.The study was divided into two stages.The pivotal trial phase included a one-week screening,12-week double-blind treatment,followed by an expanded phase which included six-week open-label treatment.The tone of the wrist,finger,thumb flexors was assessed at baseline and at weeks 0,1,4,6,8,12,16 and 18 using Modified Ashworth Scale (MAS),disability in activities of daily living was rated using the Disability Assessment Scale and impaction on pain,muscle tone and deformity was assessed using the Global Assessment Scale.The primary endpoint was the score difference between botulinum toxin type A and placebo groups in the tone of the wrist flexor using MAS at six weeks compared to baseline.Results Muscle tone MAS score in the wrist flexor of botulinum toxin type A and placebo groups at six weeks changed-1.00 (-2.00,-1.00) and 0.00 (-0.50,0.00) respectively from baseline.Botulinum toxin type A was significantly superior to placebo for the primary endpoint (Z =6.618,P < 0.01).The safety measurement showed 10 subjects who received botulinum toxin type A had 13 adverse reactions,with an incidence of 8.47% (10/118),and three subjects who received placebo had three adverse reactions,with an incidence of 5.00% (3/60) during the pivotal trial phase.All adverse reactions were mild to moderate,none serious.There was no significant difference in adverse reactions incidence between the botulinum toxin type A and the placebo groups.During the expanded phase three subjects had four adverse reactions and the incidence was 1.95%.All adverse reactions were mild,none serious.Conclusion Botulinum toxin type A was found to be safe and efficacious for the treatment of post-stroke upper limb spasticity.Clinical Trial Registration:China Drug Trials,CTR20131191
7.Summary of the 30th International Symposium on Amyotrophic Lateral Sclerosis-Motor Neuron Disease
Xiaoli YAO ; Huifang SHANG ; Xiaoguang LI ; Yan CHEN ; Min ZHANG ; Qi NIU ; Zhangyu ZOU ; Xunzhe YANG ; Junling WANG ; Cunjiang LI ; Dehong LU ; Jiahong LU ; Xusheng HUANG ; Dongsheng FAN ; Liying CUI
Chinese Journal of Neurology 2020;53(10):855-860
The 30th International Symposium on Amyotrophic Lateral Sclerosis-Motor Neuron Disease was held in Perth, Australia from December 4 to 6, 2019. This article mainly introduces the clinical research of this meeting, including epidemiology, non-motor symptoms, auxiliary examinations and biomarkers, etc., while the basic research includes genomics and genetics, protein metabolism abnormalities, neuroimmunity and inflammation, synapse pathology and preclinical treatment strategies,
8.Attitudes and influencing factors of transplantation-related populations towards kidney xenotransplantation
Ying XU ; Jiahong CHEN ; Songzhe HE ; Tao LI ; Jinhao QI ; Yi WANG
Organ Transplantation 2023;14(5):683-690
Objective To investigate the attitudes and influencing factors of transplantation-related populations towards kidney xenotransplantation. Methods From June 2022 to January 2023, stratified random sampling was performed from patients awaiting kidney transplantation, patients after kidney transplantation, patients' relatives and medical students. Four hundred subjects were collected from each population and 1600 subjects were investigated using a self-designed questionnaire. Baseline data of the respondents, their attitudes towards kidney xenotransplantation and the reasons of rejecting kidney xenotransplantation were analyzed. The influencing factors of attitudes towards kidney xenotransplantation were also identified. Results A total of 1 493 valid questionnaires were collected, and the questionnaire retrieval rate was 93.31%. About 93.10% of the respondents accepted allogeneic kidney transplantation, and 66.78% had heard of kidney xenotransplantation. Seven hundred and ninety-five respondents suggested that they could accept kidney xenotransplantation "when kidney xenotransplantation and allogeneic kidney transplantation yielded the same results and risks". Six hundred and ninety-eight respondents indicated that they were "unable" or "uncertain" whether they could accept kidney xenotransplantation (χ2=16.409,P=0.001). Among these 698 respondents, the proportion of them who were willing to accept kidney xenotransplantation when they did not meet the conditions of allogeneic kidney transplantation was 10.9%. About 35.8% of respondents were willing to accept kidney xenotransplantation if it yielded less risk and better prognosis compared with allogeneic kidney transplantation. If the time of awaiting kidney xenotransplantation was shorter than that of allogeneic kidney transplantation, 21.2% were willing to accept kidney xenotransplantation. If the cost of kidney xenotransplantation was less than that of allogeneic kidney transplantation, 24.5% of them were willing to accept kidney xenotransplantation. The main reasons of rejecting kidney xenotransplantation included surgical risk and other unknown risks. Multivariate analysis showed that respondents residing in cities and towns for a long period of time, those who accept allogeneic kidney transplantation and those who have heard of kidney xenotransplantation showed more positive attitudes towards kidney xenotransplantation. Conclusions Different transplantation-related populations have different attitudes towards kidney xenotransplantation, and the overall attitudes are positive. Active promotion of kidney xenotransplantation research and carrying out relevant popular science education contribute to improving public attitudes towards the acceptance of kidney xenotransplantation.
9. Summary of the Twenty-ninth International Symposium on Amyotrophic Lateral Sclerosis-Motor Neuron Disease
Xusheng HUANG ; Liying CUI ; Dongsheng FAN ; Xiaoguang LI ; Mingsheng LIU ; Huifang SHANG ; Xiaoli YAO ; Jiahong LU ; Min ZHANG ; Yan CHEN ; Qi NIU ; Xueping CHEN
Chinese Journal of Neurology 2019;52(10):866-871
The 29th International Symposium on Amyotrophic Lateral Sclerosis (ALS)-Motor Neuron Disease was held in Glasgow from December 7 to 9, 2018. The symposium was divided into 23 topics, with 109 special reports and paper′s exchange and 515 posters exchange. This article briefly introduces some topics of the symposium, involving basic researches, clinical researches and clinical trials. Among these, basic researches include genetics and genomics, axonal degeneration, disease models, and preclinical therapeutic strategies; Clinical researches include epidemiology, clinical progression, cognitive and psychological change, neuropathology, neurophysiology, neuroimaging and biomarkers.